We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

Schedule an appointment today

Find University Hospitals Doctors

Daniel Craven, MD

Daniel Craven, MD


Pediatric Pulmonology

Accepting New Patients

Schedule an Appointment



  • Program Director, Pediatric Interstitial Lung Disease, UH Cleveland Medical Center
  • Program Director, Pediatric Pulmonology Fellowship, UH Cleveland Medical Center
  • Associate Professor, CWRU School of Medicine

Daniel Craven, MD, is a specialist and clinical educator in pediatric pulmonary (lung) diseases in the Division of Pediatric Pulmonology, Allergy, Immunology and Sleep Medicine, medical director of respiratory therapy, clinical director of the Technology Dependent Center, and co-director of the Children’s Asthma Center at University Hospitals Rainbow Babies & Children’s Hospital. He sees patients at UH Rainbow Babies & Children’s Main Campus, UH Medina and UH Westlake health centers.

Dr. Craven has been voted to Cleveland Magazine’s Top Doctors multiple times and was recently selected for “Best Doctors in America.”

Dr. Craven is board certified in pediatric pulmonology. His special interests include pediatric asthma, bronchiectasis, mechanical ventilation in children, vocal cord dysfunction, respiratory complications of sickle cell anemia, respiratory complications of Down syndrome, diffuse parenchymal lung disease, and rare lung disease. He was appointed to the UH Rainbow Babies & Children’s Hospital medical staff in 1996 and was appointed as faculty in 2000.

Dr. Craven is a graduate of Duke University, Durham, N.C., graduating cum laude with a bachelor’s degree in psychology. He earned his medical degree from Case Western Reserve University School of Medicine and served his residency and chief residency in pediatrics and a fellowship in pediatric pulmonology at UH Rainbow Babies & Children’s Hospital.

Dr. Craven’s academic interests include asthma, technology dependent children, lung disease associated with Sickle Cell Anemia and Down Syndrome and Rare Diffuse Lung disease.

Dr. Craven has authored or coauthored scientific papers in pediatric and pulmonary medicine journals and has been an invited presenter at The American Thoracic Society International Conference as well as at local medical symposia and Grand Rounds, speaking on pediatric asthma and a wide spectrum of pediatric pulmonary disorders.


  • Allergic Respiratory Disorders
  • Asthma
  • Bronchitis
  • Bronchopulmonary Dysplasia
  • Bronchoscopy
  • Childhood Interstitial Lung Disease
  • Children Dependent on Mechanical Ventilation
  • Chronic Cough
  • Chronic Lung Disease
  • Cystic Fibrosis
  • Exercise Associated Dyspnea
  • Hemoptysis
  • Pulmonary Complications of Trisomy 21
  • Rare Lung Disease
  • Recurrent Pneumonia
  • Sickle Cell Respiratory Disorders
  • Swallowing Disorders
  • Vocal Cord Dysfunction
  • Wheezing

Languages Spoken


Office Locations

CMC RBC Ste 604

11100 Euclid Ave
Suite: 604
Cleveland, OH 44106

Rainbow Pediatric Specialty Center

29160 Center Ridge Rd
Suite: A
Westlake, OH 44145

Pediatric Specialties

4001 Carrick Dr
Suite: 220
Medina, OH 44256

Certifications & Memberships

  • Pediatric Pulmonology - American Board of Pediatrics


Fellowship | Pediatric Pulmonology
Pediatric Pulmonology - University Hospitals Of Cleveland (1997 - 2000)

Residency | Pediatrics/Chief Resident
Pediatrics/Chief Resident - University Hospitals Of Cleveland (1996 - 1997)

Residency | Pediatrics
Pediatrics - University Hospitals Of Cleveland (1994 - 1996)

Internship | Pediatrics
Pediatrics - University Hospitals Of Cleveland (1993 - 1994)

Medical Education
Case Western Reserve University School Of Medicine (1993)

Duke University (1987)

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Daniel Craven did not disclose any Outside Relationships with Industry.